$74.70
00.00%
Pre-Market: 4:38 PM EDT
15 minutes delayed
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for Intra-Cellular Therapies in recent months.
Browse guidance and forecast on all stocks.